132 results on '"Chang, Lauren A."'
Search Results
2. Intranasal SARS-CoV-2 Omicron variant vaccines elicit humoral and cellular mucosal immunity in female mice
3. A Double-blind, Randomized, Placebo-controlled plus Open Trial of Adjunctive Suvorexant for Treatment-resistant Insomnia in Patients with Bipolar Disorder
4. Big Streamlining For Small Subdivision Developers
5. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters
6. Ally, adversary, or arbitrator? The context-dependent role of eosinophils in vaccination for respiratory viruses and subsequent breakthrough infections.
7. Enhanced mucosal B- and T-cell responses against SARS-CoV-2 after heterologous intramuscular mRNA prime/intranasal protein boost vaccination with a combination adjuvant.
8. Plitidepsin as an Immunomodulator against Respiratory Viral Infections
9. Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial
10. Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian hamsters
11. Host immune responses associated with SARS-CoV-2 Omicron infection result in protection or pathology during reinfection depending on mouse genetic background.
12. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
13. Lipid Nanoparticle Encapsulation Empowers Poly(I:C) to Activate Cytoplasmic RLRs and Thereby Increases Its Adjuvanticity.
14. Lipid Nanoparticle Encapsulation Empowers Poly(I:C) to Activate Cytoplasmic RLRs and Thereby Increases Its Adjuvanticity
15. Influenza breakthrough infection in vaccinated mice is characterized by non-pathological lung eosinophilia
16. Episode accumulation associated with hastened recurrence and delayed recovery in bipolar disorder
17. Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian Hamsters
18. Characterization of Lung Eosinophil Subsets During Respiratory Viral Infection in Mice with Pre-Existing Immunity
19. Adjuvant skewing of host immune response to vaccination and subsequent infection with influenza virus
20. SARS-CoV-2 Ancestral and Variant of Concern Breakthrough infections boost both cross-reactive cellular and humoral immune responses in mRNA-vaccinated Hamsters.
21. Influenza breakthrough infection in vaccinated mice is characterized by nonpathological lung eosinophilia.
22. A prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccine
23. Tardigrades of the canopy: Evidence of stratification
24. S1531 How Type of Office Visit Influences Attitudes and Preferences for Telemedicine
25. Elicitation of pneumovirus-specific B cell responses by a prefusion-stabilized respiratory syncytial virus F subunit vaccine
26. Vaccination modulates pulmonary eosinophil subsets upon breakthrough influenza infection.
27. Recurrent respiratory syncytial virus infection in a CD14 deficient patient
28. Upgrade Rate and Imaging Features of Atypical Apocrine Lesions
29. Recurrent Respiratory Syncytial Virus Infection in a CD14-Deficient Patient
30. Chimeric Fusion (F) and Attachment (G) Glycoprotein Antigen Delivery by mRNA as a Candidate Nipah Vaccine
31. Expanding bipolar outreach during college
32. Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial
33. Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants
34. COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge
35. T Lymphocyte-Directed Gene Therapy for ADA$^-$ SCID: Initial Trial Results After 4 Years
36. Expression of Biologically Active Human Interleukin 1 Subpeptides by Transfected Simian COS Cells
37. Fr096 PERCEPTIONS OF TELEMEDICINE OFFICE VISITS DURING THE COVID-19 PANDEMIC
38. Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses
39. Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants
40. Prefrontal executive function and [D.sub.1], [D.sub.3], 5-[HT.sub.2A] and 5-[HT.sub.6] receptor gene variations in healthy adults
41. Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
42. Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes
43. SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness
44. Molecular Dissection Of Human Antibody Responses Following Prefusion-Stabilized RSV F Vaccination
45. T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years
46. 2884 How Delay in Colonoscopy Impacts Diagnosis of Significant Medical Conditions
47. Epitope-Specific Serological Assays for RSV: Conformation Matters
48. The Impact of the Affordable Care Act on Colonoscopy Cancellation Rates
49. Longer-Term Effectiveness and Tolerability of Adjunctive Open Lurasidone in Patients With Bipolar Disorder
50. A proof of concept for structure-based vaccine design targeting RSV in humans.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.